Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
暂无分享,去创建一个
G. Inman | P. ten Dijke | Gareth J Inman | Blanca Herrera | Maarten van Dinther | Peter Ten Dijke | B. Herrera | M. van Dinther | M. V. van Dinther | Maarten van Dinther
[1] M. Follettie,et al. Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] Charles C Hong,et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.
[3] W. E. Gye,et al. CANCER RESEARCH , 1923, British medical journal.
[4] M. Nachtigal,et al. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. , 2008, Gene.
[5] J. Inman,et al. Bmc Cell Biology a Rapid and Sensitive Bioassay for the Simultaneous Measurement of Multiple Bone Morphogenetic Proteins. Identification and Quantification of Bmp4, Bmp6 and Bmp9 in Bovine and Human Serum , 2022 .
[6] M. V. Dinther,et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.
[7] Mallika Singh,et al. Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.
[8] S. Ross,et al. How the Smads regulate transcription. , 2008, The international journal of biochemistry & cell biology.
[9] V. Rosen,et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. , 1995, Endocrinology.
[10] K. Miyazono,et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. , 1993, Oncogene.
[11] P. G. Knight,et al. FOCUS ON TGF-? SIGNALLING: TGF-B SUPERFAMILY MEMBERS AND OVARIAN FOLLICLE DEVELOPMENT , 2006 .
[12] C. Hill,et al. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.
[13] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[14] L. David,et al. Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.
[15] R. Thies,et al. Bone Morphogenetic Protein-9 , 2000, The Journal of Biological Chemistry.
[16] Y. Sasai,et al. Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4 , 1996, Cell.
[17] Phil G Knight,et al. TGF-beta superfamily members and ovarian follicle development. , 2006, Reproduction.
[18] D. Katsaros,et al. Chordin is underexpressed in ovarian tumors and reduces tumor cell motility , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] A. Phongdara,et al. Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones. , 2006, International journal of oral and maxillofacial surgery.
[20] Mallika Singh,et al. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis , 2003, Nature Biotechnology.
[21] F. Otsuka,et al. The role of bone morphogenetic proteins in ovarian function. , 2019, Reproduction (Cambridge, England) Supplement.
[22] T J Hudson,et al. Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer , 2006, British Journal of Cancer.
[23] P. ten Dijke,et al. Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.
[24] L. Dubeau,et al. The cell of origin of ovarian epithelial tumours. , 2008, The Lancet. Oncology.
[25] L. David,et al. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.
[26] P. Leung,et al. Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.
[27] K. Miyazono,et al. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[28] C. Le Page,et al. BMP-2 signaling in ovarian cancer and its association with poor prognosis , 2009, Journal of ovarian research.
[29] E. Beutler,et al. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 , 2006, Proceedings of the National Academy of Sciences.
[30] M. Nachtigal,et al. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. , 2003, Endocrinology.
[31] Manas Kumar Majumdar,et al. BMP‐2 and BMP‐9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL‐1 , 2001, Journal of cellular physiology.
[32] R. Curi,et al. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. , 2008, Endocrinology.
[33] Li-Xin Xiang,et al. Bone morphogenetic protein. , 2007, Biochemical and biophysical research communications.
[34] Gerard C Blobe,et al. Role of transforming growth factor-beta superfamily signaling pathways in human disease. , 2008, Biochimica et biophysica acta.
[35] M. Goumans,et al. Controlling cell fate by bone morphogenetic protein receptors , 2003, Molecular and Cellular Endocrinology.
[36] J. Blusztajn,et al. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. , 2000, Science.
[37] L. Spender,et al. TGF-β induces apoptosis in human B cells via transcriptional regulation of BIK and BCL-XL , 2009, Cell Death and Differentiation.